WEALTH on WIRE

Biotech is always an exciting sector for market players to invest in. In Biotech stock, risk is high but the returns are also sweet. Generally Biotech  firms are struggling to stay in business as research and developments costs eat through their cash positions.

Unfortunately, the only way that biotech companies have a chance at coming to market with a successful drug is by spending money on R&D.  Every Biotech or pharmacy company has to pass many hurdles before they come up with a successful product in the market. If you take the history of Biotech companies, most of them had been at the brink of Bankruptcy at one point of their life.  This is primarily due to the lack of income during the research and development stage of the product. It takes long to successfully develop, get approved by FDA and successfully market the product.  Check to see whether they have enough money to survive through this phase.

 A good way to gauge how well a biotech company is doing is to simply follow the FDA trials for its key drugs. If you follow the trials, you can see if any potential drug is advancing or showing positive results. Of course, these trials make for great catalysts for the stocks, especially when there is bullish news.

Keep watch on companies coming up on trials for phase II and phase III studies of FDA drug approval. Combine that key information with an unemotional view of a potential company’s stock chart, and you might be able to spot some big opportunities in the biotech sector.

There are a number of companies poised to report key clinical results, it might be well worth the time to evaluate their charts. So watch out for FDA announcements.